Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Azaya Therapeutics Inc.

www.azayatherapeutics.com

Latest From Azaya Therapeutics Inc.

Sun’s Generic Doxil Clears FDA; Janssen Uses Alternative Manufacturing Process

FDA approval of the first generic version of Janssen’s Doxil to curtail drug’s shortage; agency also permits Janssen to use an alternative manufacturing process.

BioPharmaceutical United States

Drug Shortages Endgame: FDA Goes On Offensive As Legislative Plot Thickens

FDA press conference on alleviating shortages shows how the agency works with industry to advance legislation that firms may not be particularly fond of themselves. But the agency still seems to face an uphill legislative battle.

BioPharmaceutical United States

Doxil Shortage Solution: FDA Chooses Middle Ground, Allows Import Of Unapproved Version

FDA is allowing Sun Pharma Global FZE to import its unapproved liposomal version of doxorubicin, Lipodox, to alleviate a shortage, but has not yet given the drug full approval.

BioPharmaceutical India

Selected Start-Ups (7/05)

In Vivo briefly summarizes the technologies of these recently founded companies: Aeres, Azaya Therapeutics, Cellular Dynamics International, Esprit Pharma, InterveXion Therapeutics and Knopp Neurosciences.
See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Azaya Therapeutics Inc.
  • Senior Management
  • Michael T Dwyer, Pres. & CEO
  • Contact Info
  • Azaya Therapeutics Inc.
    Phone: (210) 341-6600
    12672 Silicon Dr.
    Ste. 150
    San Antonio, TX 78249
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register